Gene Therapy for GM1 Gangliosidosis Mediated by AAV Vector Carrying BBB-Penetrable Enzyme

被引：0

作者：

Matsushima, Saki ^{[1
]}

Iizuka, Sayoko ^{[1
]}

Kinoshita, Masafumi ^{[2
]}

Takagi, Haruna ^{[2
]}

Iizuka, Shunsuke ^{[2
]}

Ohtsuki, Kota ^{[2
]}

Imakiire, Atsushi ^{[2
]}

Nagashima, Takashi ^{[3
]}

Okamoto, Shinichiro ^{[4
,5
]}

Higuchi, Takashi ^{[1
]}

Shimada, Yohta ^{[1
]}

Hioki, Hiroyuki ^{[4
]}

Sonoda, Hiroyuki ^{[2
]}

Watabe, Ayako M. ^{[3
]}

Ohashi, Toya ^{[6
]}

Kobayashi, Hiroshi ^{[1
]}

机构：

[1] Jikei Univ, Div Gene Therapy, Res Ctr Med Sci, Sch Med, Tokyo, Japan

[2] JCR Pharmaceut Co Ltd, Kobe, Hyogo, Japan

[3] Jikei Univ, Inst Clin Med & Res, Res Ctr Med Sci, Sch Med, Chiba, Japan

[4] Juntendo Univ, Dept Neuroanat, Grad Sch Med, Tokyo, Japan

[5] Juntendo Univ, Adv Res Inst Hlth Sci, Tokyo, Japan

[6] Jikei Univ, Sch Nursing, Tokyo, Japan

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1344

引用

页码：635 / 636

页数：2

共 50 条

[31] AAV Gene Therapy Normalizes Disease Phenotype and Extends Life Span >Four-Fold in Feline GM1 Gangliosidosis
Johnson, Aime K.
McCurdy, Victoria J.
Bradbury, Allison M.
Gray-Edwards, Heather
Randle, Ashley N.
Hwang, Misako
Cox, Nancy R.
Leroy, Stanley G.
Sena-Esteves, Miguel
Martin, Douglas R.
MOLECULAR THERAPY, 2013, 21 : S227 - S227
[32] Intracerebral cell transplantation therapy for murine GM1 gangliosidosis
Sawada, Tomo
Tanakaa, Akemi
Higaki, Katsumi
Takamura, Ayumi
Nanba, Eiji
Seto, Toshiyuki
Maeda, Mitsuyo
Yamaguchi, Etsuko
Matsuda, Junichiro
Yamano, Tunekazu
BRAIN & DEVELOPMENT, 2009, 31 (10): : 717 - 724
[33] Gene mediated enzyme replacement therapy of Fabry disease by AAV serotype 1 vector
Ogawa, K
Hirai, Y
Zenri, K
Fukunaga, Y
Shimada, T
JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 377 - 378
[34] A Single Injection of an Optimized AAV Vector into Cerebrospinal Fluid Prevents Neurological Disease in a Murine Model of GM1 Gangliosidosis
Hinderer, Christian
Nosratbakhsh, Brenden
Katz, Nathan
Wilson, James M.
MOLECULAR THERAPY, 2019, 27 (04) : 372 - 372
[35] Phase 1/2 Trial of AXO-AAV-GM1 Gene Therapy for the Treatment of Infantile- and Juvenile-onset GM1 Gangliosidosis: Preliminary Results
Tifft, C.
D'souza, P.
Johnston, J.
Acosta, M.
Rothermel, C.
Thurm, A.
Karunakara, A.
Thorp, B.
Ross, P.
Jameson, J.
Vaughn, T.
Valencia, D.
De Boever, E.
Corcoran, G.
ANNALS OF NEUROLOGY, 2021, 90 : S98 - S98
[36] Attenuation of ganglioside GM1 accumulation in the brain of GM1 gangliosidosis mice by neonatal intravenous gene transfer
Takaura, N
Yagi, T
Maeda, M
Nanba, E
Oshima, A
Suzuki, Y
Yamano, T
Tanaka, A
GENE THERAPY, 2003, 10 (17) : 1487 - 1493
[37] Comparing GM1 gangliosidosis patients treated and untreated with gene therapy: Longitudinal white matter changes in GM1 using differential tractography
Acosta, Maria T.
Lewis, Connor J.
Vardar, Zeynep
Johnston, Jean M.
Kuhn, Anna
D'Souza, Precilla
Shazeeb, Mohammed Salman
Tifft, Cynthia J.
MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
[38] Immune Modulation Preceding AAV9-GLB1 Gene Therapy Preserves the Possibility for Re-Dosing in Children with GM1 Gangliosidosis
D'Souza, Precill
Coleman, Kirsten E.
Rothermel, Caroline E.
Corti, Manuela
Tifft, Cynthia J.
Byrne, Barry J.
MOLECULAR THERAPY, 2021, 29 (04) : 92 - 93
[39] Attenuation of ganglioside GM1 accumulation in the brain of GM1 gangliosidosis mice by neonatal intravenous gene transfer
N Takaura
T Yagi
M Maeda
E Nanba
A Oshima
Y Suzuki
T Yamano
A Tanaka
Gene Therapy, 2003, 10 : 1487 - 1493
[40] Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis
Gross, Amanda L.
Gray-Edwards, Heather L.
Bebout, Cassie N.
Ta, Nathan L.
Nielsen, Kayly
Brunson, Brandon L.
Mercado, Kalajan R. Lopez
Osterhoudt, Devin E.
Batista, Ana Rita
Maitland, Stacy
Seyfried, Thomas N.
Sena-Esteves, Miguel
Martin, Douglas R.
BRAIN, 2022, 145 (02) : 655 - 669

← 1 2 3 4 5 →